CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
SELNET aims to enhance the diagnosis and treatment of rare cancers, particularly sarcomas, by establishing a collaborative network of specialists across Europe and Latin America. The project focuses on improving clinical practices and patient outcomes through better resources and education.
Rare cancersRare cancers are associated with poor survival, accounting for 22% of new cancer diagnoses in Europe, and 30% of cancer deaths.
Sarcomas are a heterogeneous group of life-threatening rare solid malignancies affecting soft and bone tissues, representing 10% of rare tumors and around 2% of adult tumors, with an incidence of 5.9/100,000/year in Europe.
Appropriate management of sarcoma patients is hindered by the absence of referral policies to reference centers (RCs), incorrect or dela…
INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Instituto Nacional de Cancerología
Mexico, Mexico
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
